Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma. (Record no. 23926788)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02009 a2200601 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516220329.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201410s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1532-1827 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1038/bjc.2014.327 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Peiró, G |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20141006 |
245 00 - TITLE STATEMENT | |
Title | Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | British journal of cancer |
Date of publication, distribution, etc. | Aug 2014 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 689-95 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Breast Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Central Nervous System Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Chemotherapy, Adjuvant |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Class I Phosphatidylinositol 3-Kinases |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | DNA Mutational Analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Neoplasm |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Enzyme Activation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kaplan-Meier Estimate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Molecular Targeted Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phosphatidylinositol 3-Kinases |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptor, ErbB-2 |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Signal Transduction |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Trastuzumab |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | src-Family Kinases |
General subdivision | antagonists & inhibitors |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ortiz-Martínez, F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gallardo, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pérez-Balaguer, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sánchez-Payá, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ponce, J J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tibau, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | López-Vilaro, L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Escuin, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Adrover, E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Barnadas, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lerma, E |
773 0# - HOST ITEM ENTRY | |
Title | British journal of cancer |
Related parts | vol. 111 |
-- | no. 4 |
-- | p. 689-95 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1038/bjc.2014.327">https://doi.org/10.1038/bjc.2014.327</a> |
Public note | Available from publisher's website |
No items available.